GEN

Transferring Viral Vector Production from Plasticware to a Fixed-Bed Bioreactor

Gene and modified cell therapies (for example, chimeric antigen receptor [CAR] T-cell therapies) in early to late clinical development are showing significant promise to treat and potentially cure ...
GEN

CCRM Partners with Membio for Developing Single-Use Bioreactor to Streamline Viral Vector Production

Officials at CCRM say they have partnered with Membio, a Canadian biotechnology company developing a 0.2–10 L benchtop single-use bioreactor system, to streamline production of viral vectors. This ...
PharmiWeb

Terumo Blood and Cell Technologies' Peer-Reviewed Publication Shows Hollow Fiber-Based Bioreactors Can Produce 8x Viral Vector-Producing Cells in Four Days

LAKEWOOD, Colorado, US, September 7 2023 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced the publication of a peer-reviewed manuscript regarding a new ...
Pharmabiz

TFBS to leverage scale-X carbo mid-scale fixed-bed bioreactor from Univercells Technologies for GMP viral vector operations

TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacific region, announced a partnership with Univercells Technologies, a leading ...
Nanowerk

Bioreactor: Enabling Controlled Biological Processes for Diverse Applications

Schematic of a typical bioreactor. Key components include the reactor tank, agitation system, feeding pump, thermal jacket, submerged aerator, and sensor probes for monitoring and maintaining optimal ...
FiercePharma

Vexed by vectors: How COVID-19 vaccine and cell and gene players are tackling the viral vector bottleneck

Bristol Myers Squibb’s cancer cell therapy Breyanzi. Johnson & Johnson and AstraZeneca’s recombinant COVID-19 vaccines. Novartis’ gene therapy Zolgensma. All of these, plus many others, are united by ...